BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 29168984)

  • 41. Transcatheter aortic valve replacement versus surgery for symptomatic severe aortic stenosis: A reconstructed individual patient data meta-analysis.
    Dowling C; Kondapally Seshasai SR; Firoozi S; Brecker SJ
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):158-166. PubMed ID: 31566902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.
    Khan MZ; Khan MU; Munir MB; Khan SU; Osman M; Balla S
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):947-955. PubMed ID: 32129573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.
    Abdelgawad AME; Hussein MA; Naeim H; Abuelatta R; Alghamdy S
    Heart Surg Forum; 2019 Aug; 22(5):E331-E339. PubMed ID: 31596707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contemporary Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Cancer.
    Guha A; Dey AK; Arora S; Cavender MA; Vavalle JP; Sabik JF; Jimenez E; Jneid H; Addison D
    J Am Heart Assoc; 2020 Jan; 9(2):e014248. PubMed ID: 31960751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time to Explore Transcatheter Aortic Valve Replacement in Younger, Low-Risk Patients.
    Sondergaard L
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2183-2185. PubMed ID: 27744040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: A randomized trial of a self-expanding prosthesis.
    Zorn GL; Little SH; Tadros P; Deeb GM; Gleason TG; Heiser J; Kleiman NS; Oh JK; Popma JJ; Adams D; Huang J; Reardon MJ
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1014-22, 1023.e1-3. PubMed ID: 26614412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low and intermediate risk: A risk specific meta-analysis of randomized controlled trials.
    Fang F; Tang J; Zhao Y; He J; Xu P; Faramand A
    PLoS One; 2019; 14(9):e0221922. PubMed ID: 31550263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of periprocedural and mid-term stroke rates and outcomes between surgical aortic valve replacement and transcatheter aortic valve replacement patients.
    Aalaei-Andabili SH; Anderson RD; Petersen JW; Beaver TM; Bavry AA; Klodell CT
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):591-597. PubMed ID: 27078127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute and 30-Day Outcomes in Women After TAVR: Results From the WIN-TAVI (Women's INternational Transcatheter Aortic Valve Implantation) Real-World Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail GW; Sharma S; Ferrer MC; Naber C; Kievit P; Faggioni M; Snyder C; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1589-600. PubMed ID: 27491609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. End-stage renal disease and severe aortic stenosis: Does valve replacement improve one-year outcomes?
    Condado JF; Maini A; Leshnower B; Thourani V; Forcillo J; Devireddy C; Mavromatis K; Sarin EL; Stewart J; Guyton R; Simone A; Keegan P; Lerakis S; Block PC; Babaliaros V
    Catheter Cardiovasc Interv; 2017 May; 89(6):1109-1115. PubMed ID: 28211605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Relation between Volume and Outcome of Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    He J; Zhang Z; Wang H; Cai L
    Cardiovasc Ther; 2020; 2020():2601340. PubMed ID: 32395180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.
    Head SJ; Reardon MJ; Deeb GM; Van Mieghem NM; Popma JJ; Gleason TG; Williams MR; Radhakrishnan S; Fremes S; Oh JK; Chang Y; Boulware MJ; Kappetein AP
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007396. PubMed ID: 30929507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk.
    Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ
    Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
    Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Midterm outcome of transcatheter versus surgical aortic valve replacement in low to intermediate risk patients: A meta-analysis of randomized controlled trials.
    Wang Y; Zhou Y; Zhang L; Zhu J
    J Cardiol; 2018 Jun; 71(6):534-539. PubMed ID: 29655505
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early readmissions after transcatheter and surgical aortic valve replacement.
    Vejpongsa P; Bhise V; Charitakis K; Vernon Anderson H; Balan P; Nguyen TC; Estrera AL; Smalling RW; Dhoble A
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):662-670. PubMed ID: 28251807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
    Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ
    JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1-Year Outcomes After Transfemoral Transcatheter or Surgical Aortic Valve Replacement: Results From the Italian OBSERVANT Study.
    Tamburino C; Barbanti M; D'Errigo P; Ranucci M; Onorati F; Covello RD; Santini F; Rosato S; Santoro G; Fusco D; Grossi C; Seccareccia F;
    J Am Coll Cardiol; 2015 Aug; 66(7):804-812. PubMed ID: 26271063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time course of the survival advantage of transcatheter over surgical aortic valve replacement: Interplay between sex and patient risk profile.
    Ueshima D; Masiero G; Schiavo A; Badawy MRA; Fraccaro C; Napodano M; Brener SJ; Tarantini G
    Catheter Cardiovasc Interv; 2019 Nov; 94(5):746-752. PubMed ID: 30821116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing the safety and efficacy of TAVR compared to SAVR in low-to-intermediate surgical risk patients with aortic valve stenosis: An overview of reviews.
    Mc Morrow R; Kriza C; Urbán P; Amenta V; Amaro JAB; Panidis D; Chassaigne H; Griesinger CB
    Int J Cardiol; 2020 Sep; 314():43-53. PubMed ID: 32434749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.